The Moderna vaccine was in combination trial and applies to skin cancer, which has seen incredible success in immune therapies. I don’t see that as a major challenge for NWBO. Glad to see their success.
Nice story. It’s turning out to be better, because of the short attack phenomenon, for many of these companies to, unfortunately, stay private and only go public on major news of success.
The companies that went public early get manipulated and ultimately distressed by short attacks and sophisticated social media pr campaigns by nefarious persons and interests. What that means in the long-run I fear is that investors won’t be able to buy their first shares in such companies until they are valued in the multiple or many billions of dollars, as latecomer investors, long after much of the really good ride has been given to the funds and private investors.
It’s really too bad.
News 
Market Data 
Discover 
AI
